Research Compendium/Shredded Stack
Stacks & FormulasResearch OnlyNot For Human Consumption

Shredded Stack

AOD-9604 + MOTS-C + Tesamorelin · Peptide Pen Shredded

A blend of three compounds, each acting on a different metabolic signalling pathway.

MECHANISM OF ACTION

The Shredded Stack brings together three compounds that each approach fat metabolism from a different angle. AOD-9604 directly triggers fat cells to break down their stored fat, without raising growth-related hormones. MOTS-C switches on the body's exercise-response system (AMPK), raising the metabolic rate, improving how the body handles sugar, and pushing muscles to use more fat for fuel in research models. Tesamorelin stimulates growth hormone to specifically target visceral fat (the fat stored deep in the abdomen around the organs), the mechanism behind its FDA approval. Because they work through three different pathways at once, the theory is that the combined effect is greater than any single compound alone.

RESEARCH APPLICATIONS

  • Multi-pathway metabolic signalling research
  • Adipose tissue research models
  • Comparative blend pharmacology

RESEARCH HIGHLIGHTS

Three distinct pathways

The components act on separate signalling routes - lipolytic, AMPK-mediated and GH-axis - which is the rationale for studying them together. See individual compound pages.

Ref: See individual compound pages

RESEARCH PROTOCOL NOTES

Available formatPen (Shredded - AOD 9604, MOTS-c, Tesamorelin - Peptide Pen)
Research contextPreclinical models combined caloric restriction with compound administration to isolate compound-specific effects on adipose tissue metabolism
Physical formSupplied lyophilised (freeze-dried powder) unless stated otherwise

Chemical Identity

Storage & Stability

2–8°C. Reconstituted blend follows most sensitive component (Tesamorelin: use within 3 hours if no preservative, or 21 days bacteriostatic).

Regulatory Status

Unscheduled in South Africa. Supplied for laboratory and research use only. Not a registered medicine, not evaluated by SAHPRA, not for human consumption. Tesamorelin component is WADA prohibited (S2).

Important - read before proceeding

This page is a summary of published scientific literature about a molecule. It is provided for research and educational purposes only. Nothing on this page is medical advice, a diagnosis, a recommendation, a prescription, or a claim that this compound treats, cures, prevents or improves any condition in humans. Research findings described here are observations reported by third-party researchers about the molecule - they are not statements about the product supplied by Bio Intelligence, and they should not be read as an expected outcome.

Compounds supplied are not registered medicines, have not been evaluated by SAHPRA, and are not for human consumption. No dosing, route of administration or usage guidance is provided by Bio Intelligence. If you have a health concern, speak to a registered healthcare practitioner.